A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

Clinical trial NCT07043946 · RECRUITING

Trial details

NCT number: NCT07043946
Sponsor: Climb Bio, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia (ITP)ITP Biologics Monoclonal Anti-CD19

Start date: 2025-06-30
Primary completion: 2027-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.